Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Kynurenic acid underlies sex-specific immune responses to COVID-19

Yuping Cai, Daniel J. Kim, Takehiro Takahashi, David I. Broadhurst, Shuangge Ma, Nicholas J.W. Rattray, Arnau Casanovas-Massana, Benjamin Israelow, Jon Klein, Carolina Lucas, Tianyang Mao, Adam J. Moore, M. Catherine Muenker, Jieun Oh, Julio Silva, Patrick Wong, Yale IMPACT Research team, Albert I. Ko, Sajid A. Khan, View ORCID ProfileAkiko Iwasaki, Caroline H. Johnson
doi: https://doi.org/10.1101/2020.09.06.20189159
Yuping Cai
1Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Kim
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takehiro Takahashi
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David I. Broadhurst
3Centre for Integrative Metabolomics & Computational Biology, School of Science, Edith Cowan University, Joondalup, 6027, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuangge Ma
4Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J.W. Rattray
5Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Casanovas-Massana
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Israelow
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
7Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Klein
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Lucas
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianyang Mao
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Moore
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Catherine Muenker
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jieun Oh
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Silva
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Wong
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
6Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sajid A. Khan
8Department of Surgery, Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Iwasaki
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
9Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Iwasaki
Caroline H. Johnson
1Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: caroline.johnson{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus disease-2019 (COVID-19) has poorer clinical outcomes in males compared to females, and immune responses underlie these sex-related differences in disease trajectory. As immune responses are in part regulated by metabolites, we examined whether the serum metabolome has sex-specificity for immune responses in COVID-19. In males with COVID-19, kynurenic acid (KA) and a high KA to kynurenine (K) ratio was positively correlated with age, inflammatory cytokines, and chemokines and was negatively correlated with T cell responses, revealing that KA production is linked to immune responses in males. Males that clinically deteriorated had a higher KA:K ratio than those that stabilized. In females with COVID-19, this ratio positively correlated with T cell responses and did not correlate with age or clinical severity. KA is known to inhibit glutamate release, and we observed that serum glutamate is lower in patients that deteriorate from COVID-19 compared to those that stabilize, and correlates with immune responses. Analysis of Genotype-Tissue Expression (GTEx) data revealed that expression of kynurenine aminotransferase, which regulates KA production, correlates most strongly with cytokine levels and aryl hydrocarbon receptor activation in older males. This study reveals that KA has a sex-specific link to immune responses and clinical outcomes, in COVID-19 infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was in part supported by a gift from the Yale University Rapid Relief Fund, Women Health Research at Yale Pilot Project Program, Fast Grant from Emergent Ventures at the Mercatus Center, Mathers Foundation, the Beatrice Kleinberg Neuwirth Fund, and the Ludwig Family Foundation. IMPACT received support from the Yale COVID-19 Research Resource Fund. A.I. is an Investigator of the Howard Hughes Medical Institute. D.J.K. was a Paul and Daisy Soros Fellow and was supported by a grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) (F30CA236466) and by a MSTP training grant from the NIH (T32GM007205, T32GM136651). S.A.K was supported by CTSA Grant Number UL1TR001863 from the National Center for Advancing Translational Science (NCATS), components of the NIH, and NIH roadmap for Medical Research, and the Lampman Research Fund in Yale Surgical Oncology. Supported was also provided by the Beatrice Kleinberg Neuwirth Fund, Yale Schools of Public Health and Medicine, and NIH U19 AI08992 awarded to A.I.K.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571, Protocol ID. 2000027690). Informed consent was obtained from all enrolled patients and healthcare workers

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Labels in Fig.1 revised

Data Availability

Untargeted metabolomics data, metabolomics protocols, and code is available on the MetaboLights data repository accession number MTBLS1987 (https://www.ebi.ac.uk/metabolights/). Clinical and immunological data is available from previous publication2.

https://www.ebi.ac.uk/metabolights/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Kynurenic acid underlies sex-specific immune responses to COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Kynurenic acid underlies sex-specific immune responses to COVID-19
Yuping Cai, Daniel J. Kim, Takehiro Takahashi, David I. Broadhurst, Shuangge Ma, Nicholas J.W. Rattray, Arnau Casanovas-Massana, Benjamin Israelow, Jon Klein, Carolina Lucas, Tianyang Mao, Adam J. Moore, M. Catherine Muenker, Jieun Oh, Julio Silva, Patrick Wong, Yale IMPACT Research team, Albert I. Ko, Sajid A. Khan, Akiko Iwasaki, Caroline H. Johnson
medRxiv 2020.09.06.20189159; doi: https://doi.org/10.1101/2020.09.06.20189159
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Kynurenic acid underlies sex-specific immune responses to COVID-19
Yuping Cai, Daniel J. Kim, Takehiro Takahashi, David I. Broadhurst, Shuangge Ma, Nicholas J.W. Rattray, Arnau Casanovas-Massana, Benjamin Israelow, Jon Klein, Carolina Lucas, Tianyang Mao, Adam J. Moore, M. Catherine Muenker, Jieun Oh, Julio Silva, Patrick Wong, Yale IMPACT Research team, Albert I. Ko, Sajid A. Khan, Akiko Iwasaki, Caroline H. Johnson
medRxiv 2020.09.06.20189159; doi: https://doi.org/10.1101/2020.09.06.20189159

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)